Resultados de la búsqueda 111-120 of 5622 for praluent side afects

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

2. Cirugía torácica - Ensayos clínicos - Mayo Clinic

   This study will help us to develop better ways to provide care and advice, develop better treatments to minimize long-term side effects, and improve the quality ...

3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

6. Medicina pulmonar - Ensayos clínicos - Mayo Clinic

   A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.

7. Medicina pulmonar - Ensayos clínicos - Mayo Clinic

   A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.

8. Medicina pulmonar - Ensayos clínicos - Mayo Clinic

   A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.

9. Cancer Physician Update e-Edition, August 2015

   Rehabilitation medicine offers pain management strategies without unwanted side effects. Heat and cold, desensitization, and gait aids and assistive devices ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...